Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/126782
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartín Loeches, Ignacio-
dc.contributor.authorPapiol, Elisabeth-
dc.contributor.authorRodríguez, Alejandro-
dc.contributor.authorDíaz, Emili-
dc.contributor.authorZaragoza, Rafael-
dc.contributor.authorGranada, Rosa-
dc.contributor.authorSocias, Lorenzo-
dc.contributor.authorBonastre, Juan-
dc.contributor.authorValverdú, Montserrat-
dc.contributor.authorPozo Laderas, Juan Carlos-
dc.contributor.authorLuque, Pilar-
dc.contributor.authorJuliá Narvaéz, Jose Antonio-
dc.contributor.authorCordero, Lourdes-
dc.contributor.authorAlbaya, Antonio-
dc.contributor.authorSerón Micas, Daniel-
dc.contributor.authorRello, Jordi-
dc.contributor.authorH1N1 SEMICYUC Working Group-
dc.date.accessioned2018-12-07T11:21:42Z-
dc.date.available2018-12-07T11:21:42Z-
dc.date.issued2011-02-22-
dc.identifier.urihttps://hdl.handle.net/2445/126782-
dc.description.abstractIntroduction: Little information exists about the impact of acute kidney injury (AKI) in critically ill patients with the pandemic 2009 influenza A (H1N1) virus infection. Methods: We conducted a prospective, observational, multicenter study in 148 Spanish intensive care units (ICUs). Patients with chronic renal failure were excluded. AKI was defined according to Acute Kidney Injury Network (AKIN) criteria. Results: A total of 661 patients were analyzed. One hundred eighteen (17.7%) patients developed AKI; of these, 37 (31.4%) of the patients with AKI were classified as AKI I, 15 (12.7%) were classified as AKI II and 66 (55.9%) were classified as AKI III, among the latter of whom 50 (75.7%) required continuous renal replacement therapy. Patients with AKI had a higher Acute Physiology and Chronic Health Evaluation II score (19.2 +/- 8.3 versus 12.6 +/- 5.9; P < 0.001), a higher Sequential Organ Failure Assessment score (8.7 +/- 4.2 versus 4.8 +/- 2.9; P < 0.001), more need for mechanical ventilation (MV) (87.3% versus 56.2%; P < 0.01, odds ratio (OR) 5.3, 95% confidence interval (CI) 3.0 to 9.4), a greater incidence of shock (75.4% versus 38.3%; P < 0.01, OR 4.9, 95% CI, 3.1 to 7.7), a greater incidence of multiorgan dysfunction syndrome (92.4% versus 54.7%; P < 0.01, OR 10.0, 95% CI, 4.9 to 20.21) and a greater incidence of coinfection (23.7% versus 14.4%; P < 0.01, OR 1.8, 95% CI, 1.1 to 3.0). In survivors, patients with AKI remained on MV longer and ICU and hospital length of stay were longer than in patients without AKI. The overall mortality was 18.8% and was significantly higher for AKI patients (44.1% versus 13.3%; P < 0.01, OR 5.1, 95% CI, 3.3 to 7.9). Logistic regression analysis was performed with AKIN criteria, and it demonstrated that among patients with AKI, only AKI III was independently associated with higher ICU mortality (P < 0.001, OR 4.81, 95% CI 2.17 to 10.62). Conclusions: In our cohort of patients with H1N1 virus infection, only those cases in the AKI III category were independently associated with mortality.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/cc10046-
dc.relation.ispartofCritical Care, 2011, vol. 15, num. R66-
dc.relation.urihttps://doi.org/10.1186/cc10046-
dc.rightscc by (c) Martin Loeches et al., 2011-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationInfluenzavirus-
dc.subject.classificationInsuficiència renal aguda-
dc.subject.otherInfluenza viruses-
dc.subject.otherAcute renal failure-
dc.titleAcute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2018-07-24T13:02:20Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Martin-LoechesI.pdf510.48 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons